首页 > 市场调查报告书 > 医疗设备

体外诊断

沙眼衣原体/淋病 (CT/NG) 检测的全球市场规模、份额和行业趋势分析报告：按产品、最终用户、检测类型、技术和地区展望，2023-2030 年预测

市场调查报告书

商品编码

1335873

沙眼衣原体/淋病 (CT/NG) 检测的全球市场规模、份额和行业趋势分析报告：按产品、最终用户、检测类型、技术和地区展望，2023-2030 年预测

Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market Size, Share & Industry Trends Analysis Report By Product, By End User, By Testing Type, By Technology, By Regional Outlook and Forecast, 2023 - 2030

出版日期: 2023年07月31日 | 出版商:

KBV Research | 英文 295 Pages | 订单完成后即时交付

价格

简介目录图表

沙眼衣原体/淋病奈瑟菌 (CT/NG) 检测市场规模预计到 2030 年将达到 28 亿美元，预测期内年复合成长率为 8.4%。

然而，变动成本（例如所需的试剂、工具和供应商设定）会增加总成本。此外，还有维护费用、保险费、实验室监督费用、管理费用（办公场地、租金、管理费等）。大量的诊断工具可能只有拥有大量资本预算的大型机构和参考实验室才能使用。另一方面，较小的实验室、诊所、独立从业者和个别从业者可能会因为资金限製而难以购买大型设备和分析设备。如此昂贵的限制可能会阻碍市场扩张。检查当前的资讯来源极为重要，因为市场状况和价格可能会发生变化，并且是推动市场下跌的主要要素。

此外，疫情的爆发最初对市场产生了负面影响。由于实验室拒绝 CT/NG 检测，更多案例未被报告，这些疾病的盛行率也随之增加。减少筛检、有限的资源和政府的社会排斥措施都在这一下降中发挥了重要作用。

产品展望

按产品，市场分为检测和试剂盒以及仪器/分析仪。在 2022 年的市场中，仪器和分析设备部门录得可观的收入份额。为了诊断此类疾病，市场上出售了各种仪器和分析仪。从那时起，新技术可能会因为市场的不断发展而不断发展。核酸增幅检查（NAAT）、自动分析仪等是CT/NG检测常用的仪器和分析仪。使用仪器和分析仪进行沙眼衣原体/淋病奈瑟菌 (CT/NG) 检测具有许多重要的优势，有助于准确、快速地检测这些疾病。

技术展望

从技术面来看，市场分为恒温核酸增幅技术、聚合酶炼式反应、免疫诊断等技术。 2022年，恒温核酸增幅技术领域的市场收入份额最高。对快速、准确诊断的需求不断增长以及捐血和输血数量的增加促进了 INAAT领域的发展。其他要素包括 CT/NG普及的提高、INAAT 的成本优势、INAAT 的周转时间以及对这些的需求。 INAAT领域在 CT/NG 诊断中的高敏感性和特异性可归因于该领域的发展。

检验类型展望

根据测试类型，市场分为实验室测试和 PoC 测试。 PoC 测试领域在 2022 年占据了市场的重要收入份额。 PoC 测试有许多术语来描述，包括「近距离患者测试」、「远端测试」、「卫星测试」和「快速诊断」。在提供护理或治疗的地方、附近或地点进行的所有测试都属于护理点测试的广泛类别。由于患者偏好的增加以及製造商对开发即时诊断的兴趣的增加，该行业不断发展。

最终用户前景

依最终用户划分，可分为诊断实验室、医院和其他最终用户。到2022年，诊断实验室部门将占据市场最大的销售份额。这些实验室使用沙眼衣原体/刚地奈瑟菌 (CT/NG) 检测来识别或诊断 CT/NG 并确定最合适的治疗方法。将收集尿液样本并检测 CT/NG 相关疾病。由于诊断专家的存在以及这些测试设施中最尖端科技的可用性，该领域的市场正在扩大。

区域展望

从区域来看，我们对北美、欧洲、亚太地区和拉丁美洲地区的市场进行了分析。 2022年，北美地区的市占率最高。北美主要引领诊断领域的技术发展。该地区拥有强大的研发基础设施，正在加速采用尖端平台和测试技术。在市场方面，北美也是几家重要公司的所在地。该地区的市场力量得益于这些公司丰富的经验、资源和成熟的分销网络。

北美洲
- 北美市场：按国家划分
  - 美国
  - 加拿大
  - 墨西哥
  - 其他北美地区
欧洲
- 欧洲市场：依国家分类
  - 德国
  - 英国
  - 法国
  - 俄罗斯
  - 西班牙
  - 义大利
  - 其他欧洲国家地区
亚太地区
- 亚太市场：依国家分类
  - 中国
  - 日本
  - 印度
  - 韩国
  - 新加坡
  - 马来西亚
  - 其他亚太地区
拉丁美洲/中东/非洲
- 拉丁美洲/中东/非洲市场：依国家分类
  - 巴西
  - 阿根廷
  - 阿拉伯聯合大公国
  - 沙乌地阿拉伯
  - 南非
  - 奈及利亚
  - 其他拉丁美洲/中东/非洲地区

第9章公司简介

Abbott Laboratories
Becton, Dickinson, and Company
ZeptoMetrix LLC（Antylia Scientific）
Danaher Corporation
F Hoffmann-La Roche Ltd.
Hologic, Inc
Thermo Fisher Scientific, Inc
Bayer AG
Qiagen NV
Siemens AG

第10章赢得沙眼衣原体/淋病奈瑟菌（CTNG）检测市场的必备条件

简介目录图表

The Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market size is expected to reach $2.8 billion by 2030, rising at a market growth of 8.4% CAGR during the forecast period.

Asia Pacific's emerging nations have seen increases in their GDPs and levels of disposable income. These developments have led to higher healthcare expenditures, modernized healthcare infrastructure, and a growing uptake of clinical laboratory technologies in Asia Pacific nations. Consequently, the Asia Pacific region would acquire approximately 2/5th share of the market by 2030. Low regulatory obstacles, improved healthcare infrastructure, an escalating patient population, an increase in infections, and rising healthcare costs are all possible causes. Additionally, compared to wealthy countries, several of these nations' regulatory systems are more flexible and business friendly. Some of the factors impacting the market are increasing funds and investments, high instances of sexually transmitted diseases (STDs) and sexually transmitted infections (STIs), and the high price of instruments.

The market has growth potential due to government programs, funding initiatives, and other initiatives supporting and promoting innovation and development. Companies might invest in infrastructure, improved diagnostic technology production, research and development, financial incentives, and support systems. By making it easier for manufacturers to get funding, they are motivated to advance CT/NG testing, resulting in ground-breaking developments in disease detection, monitoring, and specialty medicine. It is anticipated that more developing nations would have access to high-quality healthcare as a result of their rapid economic growth and rising healthcare costs. This is seen as an indication that the market is expanding. The frequency of sexually transmitted infections (STIs) is increasing globally, which will be a key factor in the market's growth rate. According to estimates from the World Health Organization (WHO), more than 1 million asymptomatic STIs are contracted each day worldwide. In 2020, an estimated 374 million new cases of one of the four STIs (gonorrhoea (82 million), chlamydia (129 million), syphilis (7.1 million), or trichomoniasis (156 million)) will be reported. Abdominal pain, urethral discharge or burning in males, genital ulcers, and vaginal discharge are all typical STI symptoms. As a result, the market is expected to expand due to the increased prevalence of STIs.

However, the variable costs of the necessary reagents, tools, and setup by the vendors raise the overall cost. Additional expenses include maintenance and insurance, laboratory supervision, and administrative costs (which include office space, rent, and administration). The vast array of diagnostic tools may only be affordable to large institutions and reference labs with substantial capital budgets. On the other hand, small laboratories, medical practices, and independent or private practitioners may have trouble affording large or bulky devices and analyzers due to capital constraints. These expensive constraints may hamper the market expansion. It is crucial to check current sources because market conditions and pricing are likely to change, which is also a key factor driving the market down.

Furthermore, the pandemic outbreak initially had a negative impact on the market. Due to the laboratories' denial of the CT/NG tests, more instances were not reported, and there was an increase in the spread of these diseases. Reduced screening, limited resources, and social alienation measures established by the government all contributed an essential role in this decline.

Product Outlook

On the basis of product, the market is segmented into assays & kits, instruments/analyzers. The instruments/analyzers segment recorded a remarkable revenue share in the market in 2022. To diagnose such diseases, various instruments and analyzers were sold in the market. Since then, new technologies might have evolved due to the market's ongoing evolution. Nucleic Acid Amplification Tests (NAATs), Automated Analyzers, etc., are some instruments and analyzers often used for CT/NG testing. Using instruments and analyzers in Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) testing provides many significant benefits that help in the accurate and speedy detection of these diseases.

Technology Outlook

On the basis of technology, the market is fragmented into isothermal nucleic acid amplification technology, polymerase chain reaction, immunodiagnostics, and other technologies. In 2022, the isothermal nucleic acid amplification technology segment registered the highest revenue share in the market. The growing demand for quick, accurate diagnoses and the rising number of blood donations and transfusions have contributed to the growth of the INAAT sector. Other factors are the rising prevalence of CT/NG, the cost advantages of INAAT, the turnaround time of INAAT, and the necessity for these things. The INAAT segment's high sensitivity and specificity in CT/NG diagnosis can be blamed for segment's growth.

Testing Type Outlook

Based on testing type, the market is classified into lab tests, and PoC tests. The PoC tests segment garnered a significant revenue share in the market in 2022. Numerous terms, including "near-patient testing," "remote testing," "satellite testing," and "rapid diagnostics," may be used to describe it. Any test carried out at, close to, or at the location where care or treatment is provided falls within the broad category of point-of-care testing. This industry experienced growth due to patients' rising preferences and manufacturers' rising attention to creating point-of-care diagnostics.

End User Outlook

By end user, the market categorised into diagnostic laboratories, hospital & clinics, and other end users. In 2022, the diagnostic laboratories segment witnessed the largest revenue share in the market. These laboratories use chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) testing to identify or diagnose CT/NG and identify the best therapies. They take urine samples which are examined for CT/NG related diseases. The market is growing in this segment as a result of the presence of highly skilled professionals for diagnostics and availability of cutting-edge technologies in such laboratories.

Regional Outlook

Region wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region generated the highest revenue share in the market. North America primarily led the development of technology in the region of diagnostics. A strong infrastructure for research and development is found in this region, which has accelerated the adoption of cutting-edge platforms and testing techniques. In the market, North America is also home to several significant businesses. The region's market dominance can be attributed to these businesses' extensive experience, resources, and established distribution networks.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Becton, Dickinson and Company, ZeptoMetrix LLC (Antylia Scientific), Danaher Corporation, F. Hoffmann-La Roche Ltd., Hologic, Inc., Thermo Fisher Scientific, Inc., Bayer AG, Qiagen N.V. and Siemens AG.

Scope of the Study

Market Segments covered in the Report:

By Product

Assays & Kits
Instruments & Analyzers

By End User

Diagnostic Laboratories
Hospitals & Clinics
Others

By Testing Type

Lab Tests
PoC Tests

By Technology

Isothermal Nucleic Acid Amplification Technology
Polymerase Chain Reaction
Immunodiagnostics
Others

By Geography

North America
- US
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA

Companies Profiled

Abbott Laboratories
Becton, Dickinson and Company
ZeptoMetrix LLC (Antylia Scientific)
Danaher Corporation
F. Hoffmann-La Roche Ltd.
Hologic, Inc.
Thermo Fisher Scientific, Inc.
Bayer AG
Qiagen N.V.
Siemens AG

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, by Product
- 1.4.2 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, by End User
- 1.4.3 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, by Testing Type
- 1.4.4 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, by Technology
- 1.4.5 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, by Geography
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
3.3 Porter's Five Forces Analysis

Chapter 4. Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product

4.1 Global Assays & Kits Market by Region
4.2 Global Instruments & Analyzers Market by Region

Chapter 5. Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User

5.1 Global Diagnostic Laboratories Market by Region
5.2 Global Hospitals & Clinics Market by Region
5.3 Global Others Market by Region

Chapter 6. Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type

6.1 Global Lab Tests Market by Region
6.2 Global PoC Tests Market by Region

Chapter 7. Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology

7.1 Global Isothermal Nucleic Acid Amplification Technology Market by Region
7.2 Global Polymerase Chain Reaction Market by Region
7.3 Global Immunodiagnostics Market by Region
7.4 Global Others Market by Region

Chapter 8. Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Region

8.1 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- 8.1.1 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
  - 8.1.1.1 North America Assays & Kits Market by Country
  - 8.1.1.2 North America Instruments & Analyzers Market by Country
- 8.1.2 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
  - 8.1.2.1 North America Diagnostic Laboratories Market by Country
  - 8.1.2.2 North America Hospitals & Clinics Market by Country
  - 8.1.2.3 North America Others Market by Country
- 8.1.3 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
  - 8.1.3.1 North America Lab Tests Market by Country
  - 8.1.3.2 North America PoC Tests Market by Country
- 8.1.4 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.1.4.1 North America Isothermal Nucleic Acid Amplification Technology Market by Country
  - 8.1.4.2 North America Polymerase Chain Reaction Market by Country
  - 8.1.4.3 North America Immunodiagnostics Market by Country
  - 8.1.4.4 North America Others Market by Country
- 8.1.5 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country
  - 8.1.5.1 US Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.1.5.1.1 US Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.1.5.1.2 US Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.1.5.1.3 US Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.1.5.1.4 US Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.1.5.2 Canada Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.1.5.2.1 Canada Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.1.5.2.2 Canada Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.1.5.2.3 Canada Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.1.5.2.4 Canada Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.1.5.3 Mexico Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.1.5.3.1 Mexico Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.1.5.3.2 Mexico Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.1.5.3.3 Mexico Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.1.5.3.4 Mexico Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.1.5.4 Rest of North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.1.5.4.1 Rest of North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.1.5.4.2 Rest of North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.1.5.4.3 Rest of North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.1.5.4.4 Rest of North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
8.2 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- 8.2.1 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
  - 8.2.1.1 Europe Assays & Kits Market by Country
  - 8.2.1.2 Europe Instruments & Analyzers Market by Country
- 8.2.2 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
  - 8.2.2.1 Europe Diagnostic Laboratories Market by Country
  - 8.2.2.2 Europe Hospitals & Clinics Market by Country
  - 8.2.2.3 Europe Others Market by Country
- 8.2.3 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
  - 8.2.3.1 Europe Lab Tests Market by Country
  - 8.2.3.2 Europe PoC Tests Market by Country
- 8.2.4 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.2.4.1 Europe Isothermal Nucleic Acid Amplification Technology Market by Country
  - 8.2.4.2 Europe Polymerase Chain Reaction Market by Country
  - 8.2.4.3 Europe Immunodiagnostics Market by Country
  - 8.2.4.4 Europe Others Market by Country
- 8.2.5 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country
  - 8.2.5.1 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.2.5.1.1 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.2.5.1.2 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.2.5.1.3 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.2.5.1.4 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.2.5.2 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.2.5.2.1 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.2.5.2.2 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.2.5.2.3 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.2.5.2.4 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.2.5.3 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.2.5.3.1 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.2.5.3.2 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.2.5.3.3 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.2.5.3.4 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.2.5.4 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.2.5.4.1 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.2.5.4.2 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.2.5.4.3 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.2.5.4.4 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.2.5.5 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.2.5.5.1 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.2.5.5.2 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.2.5.5.3 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.2.5.5.4 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.2.5.6 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.2.5.6.1 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.2.5.6.2 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.2.5.6.3 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.2.5.6.4 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.2.5.7 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.2.5.7.1 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.2.5.7.2 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.2.5.7.3 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.2.5.7.4 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
8.3 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- 8.3.1 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
  - 8.3.1.1 Asia Pacific Assays & Kits Market by Country
  - 8.3.1.2 Asia Pacific Instruments & Analyzers Market by Country
- 8.3.2 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
  - 8.3.2.1 Asia Pacific Diagnostic Laboratories Market by Country
  - 8.3.2.2 Asia Pacific Hospitals & Clinics Market by Country
  - 8.3.2.3 Asia Pacific Others Market by Country
- 8.3.3 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
  - 8.3.3.1 Asia Pacific Lab Tests Market by Country
  - 8.3.3.2 Asia Pacific PoC Tests Market by Country
- 8.3.4 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.3.4.1 Asia Pacific Isothermal Nucleic Acid Amplification Technology Market by Country
  - 8.3.4.2 Asia Pacific Polymerase Chain Reaction Market by Country
  - 8.3.4.3 Asia Pacific Immunodiagnostics Market by Country
  - 8.3.4.4 Asia Pacific Others Market by Country
- 8.3.5 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country
  - 8.3.5.1 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.3.5.1.1 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.3.5.1.2 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.3.5.1.3 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.3.5.1.4 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.3.5.2 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.3.5.2.1 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.3.5.2.2 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.3.5.2.3 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.3.5.2.4 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.3.5.3 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.3.5.3.1 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.3.5.3.2 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.3.5.3.3 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.3.5.3.4 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.3.5.4 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.3.5.4.1 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.3.5.4.2 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.3.5.4.3 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.3.5.4.4 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.3.5.5 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.3.5.5.1 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.3.5.5.2 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.3.5.5.3 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.3.5.5.4 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.3.5.6 Malaysia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.3.5.6.1 Malaysia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.3.5.6.2 Malaysia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.3.5.6.3 Malaysia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.3.5.6.4 Malaysia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.3.5.7 Rest of Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.3.5.7.1 Rest of Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.3.5.7.2 Rest of Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.3.5.7.3 Rest of Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.3.5.7.4 Rest of Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
8.4 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- 8.4.1 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
  - 8.4.1.1 LAMEA Assays & Kits Market by Country
  - 8.4.1.2 LAMEA Instruments & Analyzers Market by Country
- 8.4.2 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
  - 8.4.2.1 LAMEA Diagnostic Laboratories Market by Country
  - 8.4.2.2 LAMEA Hospitals & Clinics Market by Country
  - 8.4.2.3 LAMEA Others Market by Country
- 8.4.3 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
  - 8.4.3.1 LAMEA Lab Tests Market by Country
  - 8.4.3.2 LAMEA PoC Tests Market by Country
- 8.4.4 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.4.4.1 LAMEA Isothermal Nucleic Acid Amplification Technology Market by Country
  - 8.4.4.2 LAMEA Polymerase Chain Reaction Market by Country
  - 8.4.4.3 LAMEA Immunodiagnostics Market by Country
  - 8.4.4.4 LAMEA Others Market by Country
- 8.4.5 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country
  - 8.4.5.1 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.4.5.1.1 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.4.5.1.2 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.4.5.1.3 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.4.5.1.4 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.4.5.2 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.4.5.2.1 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.4.5.2.2 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.4.5.2.3 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.4.5.2.4 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.4.5.3 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.4.5.3.1 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.4.5.3.2 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.4.5.3.3 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.4.5.3.4 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.4.5.4 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.4.5.4.1 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.4.5.4.2 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.4.5.4.3 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.4.5.4.4 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.4.5.5 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.4.5.5.1 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.4.5.5.2 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.4.5.5.3 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.4.5.5.4 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.4.5.6 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.4.5.6.1 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.4.5.6.2 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.4.5.6.3 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.4.5.6.4 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
  - 8.4.5.7 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
    - 8.4.5.7.1 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
    - 8.4.5.7.2 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
    - 8.4.5.7.3 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
    - 8.4.5.7.4 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology

Chapter 9. Company Profiles

9.1 Abbott Laboratories
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expense
- 9.1.5 Recent strategies and developments:
  - 9.1.5.1 Trials & Approvals:
- 9.1.6 SWOT Analysis
9.2 Becton, Dickinson, and Company
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 Recent strategies and developments:
  - 9.2.5.1 Product Launches and Product Expansions:
- 9.2.6 SWOT Analysis
9.3 ZeptoMetrix LLC (Antylia Scientific)
- 9.3.1 Company Overview
- 9.3.2 SWOT Analysis
9.4 Danaher Corporation
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expense
- 9.4.5 SWOT Analysis
9.5 F. Hoffmann-La Roche Ltd.
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expense
- 9.5.5 Recent strategies and developments:
  - 9.5.5.1 Trials & Approvals:
- 9.5.6 SWOT Analysis
9.6 Hologic, Inc.
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Segmental and Regional Analysis
- 9.6.4 Research & Development Expenses
- 9.6.5 SWOT Analysis
9.7 Thermo Fisher Scientific, Inc.
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.7.5 SWOT Analysis
9.8 Bayer AG
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Segmental and Regional Analysis
- 9.8.4 Research & Development Expense
- 9.8.5 SWOT Analysis
9.9 Qiagen N.V.
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Regional Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 SWOT Analysis
9.10. Siemens AG
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Segmental and Regional Analysis
- 9.10.4 Research & Development Expense
- 9.10.5 SWOT Analysis

Chapter 10. Winning Imperative for Chlamydia trachomatis/Neisseria gonorrhoeae (CTNG) Testing Market

简介目录图表

LIST OF TABLES

TABLE 1 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 2 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 3 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 4 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 5 Global Assays & Kits Market by Region, 2019 - 2022, USD Million
TABLE 6 Global Assays & Kits Market by Region, 2023 - 2030, USD Million
TABLE 7 Global Instruments & Analyzers Market by Region, 2019 - 2022, USD Million
TABLE 8 Global Instruments & Analyzers Market by Region, 2023 - 2030, USD Million
TABLE 9 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 10 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 11 Global Diagnostic Laboratories Market by Region, 2019 - 2022, USD Million
TABLE 12 Global Diagnostic Laboratories Market by Region, 2023 - 2030, USD Million
TABLE 13 Global Hospitals & Clinics Market by Region, 2019 - 2022, USD Million
TABLE 14 Global Hospitals & Clinics Market by Region, 2023 - 2030, USD Million
TABLE 15 Global Others Market by Region, 2019 - 2022, USD Million
TABLE 16 Global Others Market by Region, 2023 - 2030, USD Million
TABLE 17 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 18 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 19 Global Lab Tests Market by Region, 2019 - 2022, USD Million
TABLE 20 Global Lab Tests Market by Region, 2023 - 2030, USD Million
TABLE 21 Global PoC Tests Market by Region, 2019 - 2022, USD Million
TABLE 22 Global PoC Tests Market by Region, 2023 - 2030, USD Million
TABLE 23 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 24 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 25 Global Isothermal Nucleic Acid Amplification Technology Market by Region, 2019 - 2022, USD Million
TABLE 26 Global Isothermal Nucleic Acid Amplification Technology Market by Region, 2023 - 2030, USD Million
TABLE 27 Global Polymerase Chain Reaction Market by Region, 2019 - 2022, USD Million
TABLE 28 Global Polymerase Chain Reaction Market by Region, 2023 - 2030, USD Million
TABLE 29 Global Immunodiagnostics Market by Region, 2019 - 2022, USD Million
TABLE 30 Global Immunodiagnostics Market by Region, 2023 - 2030, USD Million
TABLE 31 Global Others Market by Region, 2019 - 2022, USD Million
TABLE 32 Global Others Market by Region, 2023 - 2030, USD Million
TABLE 33 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Region, 2019 - 2022, USD Million
TABLE 34 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Region, 2023 - 2030, USD Million
TABLE 35 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 36 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 37 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 38 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 39 North America Assays & Kits Market by Country, 2019 - 2022, USD Million
TABLE 40 North America Assays & Kits Market by Country, 2023 - 2030, USD Million
TABLE 41 North America Instruments & Analyzers Market by Country, 2019 - 2022, USD Million
TABLE 42 North America Instruments & Analyzers Market by Country, 2023 - 2030, USD Million
TABLE 43 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 44 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 45 North America Diagnostic Laboratories Market by Country, 2019 - 2022, USD Million
TABLE 46 North America Diagnostic Laboratories Market by Country, 2023 - 2030, USD Million
TABLE 47 North America Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
TABLE 48 North America Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
TABLE 49 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 50 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 51 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 52 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 53 North America Lab Tests Market by Country, 2019 - 2022, USD Million
TABLE 54 North America Lab Tests Market by Country, 2023 - 2030, USD Million
TABLE 55 North America PoC Tests Market by Country, 2019 - 2022, USD Million
TABLE 56 North America PoC Tests Market by Country, 2023 - 2030, USD Million
TABLE 57 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 58 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 59 North America Isothermal Nucleic Acid Amplification Technology Market by Country, 2019 - 2022, USD Million
TABLE 60 North America Isothermal Nucleic Acid Amplification Technology Market by Country, 2023 - 2030, USD Million
TABLE 61 North America Polymerase Chain Reaction Market by Country, 2019 - 2022, USD Million
TABLE 62 North America Polymerase Chain Reaction Market by Country, 2023 - 2030, USD Million
TABLE 63 North America Immunodiagnostics Market by Country, 2019 - 2022, USD Million
TABLE 64 North America Immunodiagnostics Market by Country, 2023 - 2030, USD Million
TABLE 65 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 66 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 67 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country, 2019 - 2022, USD Million
TABLE 68 North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country, 2023 - 2030, USD Million
TABLE 69 US Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 70 US Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 71 US Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 72 US Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 73 US Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 74 US Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 75 US Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 76 US Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 77 US Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 78 US Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 79 Canada Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 80 Canada Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 81 Canada Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 82 Canada Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 83 Canada Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 84 Canada Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 85 Canada Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 86 Canada Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 87 Canada Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 88 Canada Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 89 Mexico Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 90 Mexico Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 91 Mexico Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 92 Mexico Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 93 Mexico Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 94 Mexico Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 95 Mexico Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 96 Mexico Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 97 Mexico Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 98 Mexico Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 99 Rest of North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 100 Rest of North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 101 Rest of North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 102 Rest of North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 103 Rest of North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 104 Rest of North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 105 Rest of North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 106 Rest of North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 107 Rest of North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 108 Rest of North America Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 109 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 110 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 111 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 112 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 113 Europe Assays & Kits Market by Country, 2019 - 2022, USD Million
TABLE 114 Europe Assays & Kits Market by Country, 2023 - 2030, USD Million
TABLE 115 Europe Instruments & Analyzers Market by Country, 2019 - 2022, USD Million
TABLE 116 Europe Instruments & Analyzers Market by Country, 2023 - 2030, USD Million
TABLE 117 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 118 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 119 Europe Diagnostic Laboratories Market by Country, 2019 - 2022, USD Million
TABLE 120 Europe Diagnostic Laboratories Market by Country, 2023 - 2030, USD Million
TABLE 121 Europe Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
TABLE 122 Europe Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
TABLE 123 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 124 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 125 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 126 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 127 Europe Lab Tests Market by Country, 2019 - 2022, USD Million
TABLE 128 Europe Lab Tests Market by Country, 2023 - 2030, USD Million
TABLE 129 Europe PoC Tests Market by Country, 2019 - 2022, USD Million
TABLE 130 Europe PoC Tests Market by Country, 2023 - 2030, USD Million
TABLE 131 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 132 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 133 Europe Isothermal Nucleic Acid Amplification Technology Market by Country, 2019 - 2022, USD Million
TABLE 134 Europe Isothermal Nucleic Acid Amplification Technology Market by Country, 2023 - 2030, USD Million
TABLE 135 Europe Polymerase Chain Reaction Market by Country, 2019 - 2022, USD Million
TABLE 136 Europe Polymerase Chain Reaction Market by Country, 2023 - 2030, USD Million
TABLE 137 Europe Immunodiagnostics Market by Country, 2019 - 2022, USD Million
TABLE 138 Europe Immunodiagnostics Market by Country, 2023 - 2030, USD Million
TABLE 139 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 140 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 141 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country, 2019 - 2022, USD Million
TABLE 142 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country, 2023 - 2030, USD Million
TABLE 143 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 144 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 145 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 146 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 147 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 148 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 149 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 150 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 151 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 152 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 153 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 154 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 155 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 156 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 157 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 158 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 159 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 160 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 161 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 162 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 163 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 164 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 165 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 166 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 167 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 168 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 169 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 170 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 171 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 172 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 173 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 174 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 175 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 176 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 177 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 178 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 179 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 180 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 181 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 182 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 183 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 184 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 185 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 186 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 187 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 188 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 189 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 190 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 191 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 192 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 193 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 194 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 195 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 196 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 197 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 198 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 199 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 200 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 201 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 202 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 203 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 204 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 205 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 206 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 207 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 208 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 209 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 210 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 211 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 212 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 213 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 214 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 215 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 216 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 217 Asia Pacific Assays & Kits Market by Country, 2019 - 2022, USD Million
TABLE 218 Asia Pacific Assays & Kits Market by Country, 2023 - 2030, USD Million
TABLE 219 Asia Pacific Instruments & Analyzers Market by Country, 2019 - 2022, USD Million
TABLE 220 Asia Pacific Instruments & Analyzers Market by Country, 2023 - 2030, USD Million
TABLE 221 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 222 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 223 Asia Pacific Diagnostic Laboratories Market by Country, 2019 - 2022, USD Million
TABLE 224 Asia Pacific Diagnostic Laboratories Market by Country, 2023 - 2030, USD Million
TABLE 225 Asia Pacific Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
TABLE 226 Asia Pacific Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
TABLE 227 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 228 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 229 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 230 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 231 Asia Pacific Lab Tests Market by Country, 2019 - 2022, USD Million
TABLE 232 Asia Pacific Lab Tests Market by Country, 2023 - 2030, USD Million
TABLE 233 Asia Pacific PoC Tests Market by Country, 2019 - 2022, USD Million
TABLE 234 Asia Pacific PoC Tests Market by Country, 2023 - 2030, USD Million
TABLE 235 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 236 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 237 Asia Pacific Isothermal Nucleic Acid Amplification Technology Market by Country, 2019 - 2022, USD Million
TABLE 238 Asia Pacific Isothermal Nucleic Acid Amplification Technology Market by Country, 2023 - 2030, USD Million
TABLE 239 Asia Pacific Polymerase Chain Reaction Market by Country, 2019 - 2022, USD Million
TABLE 240 Asia Pacific Polymerase Chain Reaction Market by Country, 2023 - 2030, USD Million
TABLE 241 Asia Pacific Immunodiagnostics Market by Country, 2019 - 2022, USD Million
TABLE 242 Asia Pacific Immunodiagnostics Market by Country, 2023 - 2030, USD Million
TABLE 243 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 244 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 245 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country, 2019 - 2022, USD Million
TABLE 246 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country, 2023 - 2030, USD Million
TABLE 247 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 248 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 249 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 250 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 251 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 252 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 253 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 254 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 255 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 256 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 257 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 258 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 259 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 260 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 261 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 262 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 263 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 264 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 265 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 266 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 267 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 268 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 269 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 270 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 271 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 272 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 273 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 274 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 275 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 276 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 277 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 278 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 279 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 280 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 281 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 282 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 283 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 284 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 285 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 286 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 287 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 288 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 289 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 290 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 291 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 292 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 293 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 294 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 295 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 296 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 297 Malaysia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 298 Malaysia Chlamydi

TABLE 317 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 318 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 319 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 320 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 321 LAMEA Assays & Kits Market by Country, 2019 - 2022, USD Million
TABLE 322 LAMEA Assays & Kits Market by Country, 2023 - 2030, USD Million
TABLE 323 LAMEA Instruments & Analyzers Market by Country, 2019 - 2022, USD Million
TABLE 324 LAMEA Instruments & Analyzers Market by Country, 2023 - 2030, USD Million
TABLE 325 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 326 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 327 LAMEA Diagnostic Laboratories Market by Country, 2019 - 2022, USD Million
TABLE 328 LAMEA Diagnostic Laboratories Market by Country, 2023 - 2030, USD Million
TABLE 329 LAMEA Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
TABLE 330 LAMEA Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
TABLE 331 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 332 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 333 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 334 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 335 LAMEA Lab Tests Market by Country, 2019 - 2022, USD Million
TABLE 336 LAMEA Lab Tests Market by Country, 2023 - 2030, USD Million
TABLE 337 LAMEA PoC Tests Market by Country, 2019 - 2022, USD Million
TABLE 338 LAMEA PoC Tests Market by Country, 2023 - 2030, USD Million
TABLE 339 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 340 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 341 LAMEA Isothermal Nucleic Acid Amplification Technology Market by Country, 2019 - 2022, USD Million
TABLE 342 LAMEA Isothermal Nucleic Acid Amplification Technology Market by Country, 2023 - 2030, USD Million
TABLE 343 LAMEA Polymerase Chain Reaction Market by Country, 2019 - 2022, USD Million
TABLE 344 LAMEA Polymerase Chain Reaction Market by Country, 2023 - 2030, USD Million
TABLE 345 LAMEA Immunodiagnostics Market by Country, 2019 - 2022, USD Million
TABLE 346 LAMEA Immunodiagnostics Market by Country, 2023 - 2030, USD Million
TABLE 347 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 348 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 349 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country, 2019 - 2022, USD Million
TABLE 350 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country, 2023 - 2030, USD Million
TABLE 351 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 352 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 353 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 354 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 355 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 356 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 357 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 358 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 359 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 360 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 361 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 362 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 363 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 364 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 365 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 366 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 367 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 368 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 369 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 370 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 371 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 372 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 373 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 374 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 375 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 376 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 377 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 378 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 379 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 380 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 381 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 382 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 383 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 384 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 385 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 386 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 387 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 388 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 389 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 390 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 391 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 392 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 393 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 394 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 395 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 396 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 397 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 398 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 399 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 400 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 401 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 402 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 403 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 404 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 405 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 406 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 407 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 408 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 409 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 410 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 411 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
TABLE 412 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
TABLE 413 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
TABLE 414 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
TABLE 415 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
TABLE 416 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
TABLE 417 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
TABLE 418 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
TABLE 419 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
TABLE 420 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
TABLE 421 Key Information - Abbott Laboratories
TABLE 422 Key information - Becton, Dickinson and Company
TABLE 423 Key Information - ZeptoMetrix LLC
TABLE 424 Key Information - Danaher Corporation
TABLE 425 Key Information - F. Hoffmann-La Roche Ltd.
TABLE 426 Key Information - Hologic, Inc.
TABLE 427 Key Information - Thermo Fisher Scientific, Inc.
TABLE 428 Key Information - Bayer AG
TABLE 429 Key Information - Qiagen N.V.
TABLE 430 Key Information - Siemens AG

List of Figures

FIG 1 Methodology for the research
FIG 2 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2030, USD Million
FIG 3 Key Impacting Factors chlamydia trachomatis/neisseria gonorrhoeae (CT/NG) testing market
FIG 4 Porter's Five Forces Analysis - Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
FIG 5 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Product, 2022
FIG 6 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Product, 2030
FIG 7 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2030, USD Million
FIG 8 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by End User, 2022
FIG 9 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by End User, 2030
FIG 10 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2030, USD Million
FIG 11 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Testing Type, 2022
FIG 12 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Testing Type, 2030
FIG 13 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2030, USD Million
FIG 14 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Technology, 2022
FIG 15 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Technology, 2030
FIG 16 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2030, USD Million
FIG 17 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Region, 2022
FIG 18 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Region, 2030
FIG 19 Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Region, 2019 - 2030, USD Million
FIG 20 SWOT Analysis: Abbott Laboratories
FIG 21 SWOT Analysis: Becton, Dickinson and company
FIG 22 SWOT Analysis: Becton, Dickinson and company
FIG 23 SWOT Analysis: Danaher Corporation
FIG 24 Swot Analysis: F. Hoffmann-La Roche Ltd.
FIG 25 Swot Analysis: Hologic, Inc.
FIG 26 Swot Analysis: Thermo Fisher Scientific, Inc.
FIG 27 Swot Analysis: Bayer AG
FIG 28 Swot Analysis: Qiagen N.V.
FIG 29 SWOT Analysis: Siemens AG

02-2729-4219

+886-2-2729-4219

License/价格

沙眼衣原体/淋病 (CT/NG) 检测的全球市场规模、份额和行业趋势分析报告：按产品、最终用户、检测类型、技术和地区展望，2023-2030 年预测

Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market Size, Share & Industry Trends Analysis Report By Product, By End User, By Testing Type, By Technology, By Regional Outlook and Forecast, 2023 - 2030

目录

第1章市场范围和调查方法

第2章市场概况

第3章市场概况

第4章全球沙眼衣原体/淋病双球菌（CT/NG）检测市场：按产品

第5章全球沙眼衣原体/淋病双球菌（CT/NG）检测市场：依最终用户分类

第6章全球沙眼衣原体/淋病双球菌（CT/NG）检测市场：依检测类型

第7章全球沙眼衣原体/淋病双球菌（CT/NG）检测市场：依技术分类

第8章全球沙眼衣原体/淋病双球菌（CT/NG）检测市场：按地区

第9章公司简介

第10章赢得沙眼衣原体/淋病奈瑟菌（CTNG）检测市场的必备条件

Scope of the Study

Table of Contents

Chapter 1. Market Scope & Methodology

Chapter 2. Market at a Glance

Chapter 3. Market Overview

Chapter 4. Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product

Chapter 5. Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User

Chapter 6. Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type

Chapter 7. Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology

Chapter 8. Global Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Region

Chapter 9. Company Profiles

Chapter 10. Winning Imperative for Chlamydia trachomatis/Neisseria gonorrhoeae (CTNG) Testing Market

LIST OF TABLES